Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Citi
Colorcon
McKinsey
Covington
US Army
Accenture
Farmers Insurance
Julphar
AstraZeneca

Generated: October 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,821,927

« Back to Dashboard

Which drugs does patent 8,821,927 protect, and when does it expire?


Patent 8,821,927 protects TYKERB and is included in one NDA. There has been one Paragraph IV challenge on Tykerb.

This patent has twenty-four patent family members in twenty-seven countries.

Summary for Patent: 8,821,927

Title:Pharmaceutical composition
Abstract: Oral pharmaceutical formulations containing ditosylate salts of 4-quinazolineamines are described as well as methods of using the same in the treatment of disorders characterized by aberrant erbB family PTK activity.
Inventor(s): Carter; Barry Howard (Kinston, NC), Campbell; Dwayne A (Durham, NC)
Assignee: SmithKline Beecham (Cork) Limited (Carrigaline, County Cork, IE)
Application Number:11/911,843
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form; Process;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Novartis Pharms Corp
TYKERB
lapatinib ditosylate
TABLET;ORAL022059-001Mar 13, 2007RXYesYes► Subscribe► SubscribeYY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 8,821,927

PCT Information
PCT FiledApril 18, 2006PCT Application Number:PCT/US2006/014447
PCT Publication Date:October 26, 2006PCT Publication Number: WO2006/113649

International Patent Family for Patent: 8,821,927

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Poland1871347► Subscribe
Peru14302006► Subscribe
New Zealand562223► Subscribe
Norway20075111► Subscribe
Mexico2007013089► Subscribe
Morocco29404► Subscribe
Lithuania1871347► Subscribe
South Korea101356748► Subscribe
South Korea20080005557► Subscribe
Japan5202302► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Farmers Insurance
Julphar
Merck
Cerilliant
Cantor Fitzgerald
Boehringer Ingelheim
AstraZeneca
Fuji
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot